Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Imiquimod for vulvar intraepithelial neoplasia and anogenital condyloma acuminata
2008-004893-42Phase 2Completed
- Sponsor
- Medical University of Vienna
- Start
- Sep 2008
- Modality
- Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of imiquimod in vulvar intraepithelial neoplasia (VIN), sponsored by Medical University of Vienna. Started Sep 2008; status: completed.
02
Drugs
imiquimod
03
Conditions
vulvar intraepithelial neoplasia (VIN)
Beyond the preview
Go deeper on 2008-004893-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-004893-42.